CWAN seller plans Rule 144 sale of 7425 common shares on NYSE

A Rule 144 notice shows that James Cox plans to sell 7425 shares of the issuer’s common stock on 12/17/2025 on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

A Rule 144 notice shows that James Cox plans to sell 7425 shares of the issuer’s common stock on 12/17/2025 on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares have an aggregate market value of $159637.50 and are part of 288154032 common shares outstanding.

The 7425 shares were acquired on 12/17/2025 by exercising stock options from the issuer for cash. The notice also lists recent sales for James Cox under a 10b5-1 sales plan, including 29700 shares sold on 11/25/2025 for $653400.00.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CWAN Rule 144 filing disclose about planned share sales?

The notice shows that James Cox plans to sell 7425 shares of the issuer’s common stock on 12/17/2025 on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $159637.50.

How many CWAN shares does James Cox plan to sell and when?

James Cox plans to sell 7425 common shares of the issuer on 12/17/2025 under Rule 144.

How were the CWAN shares in this Rule 144 notice acquired?

The 7425 shares to be sold were acquired on 12/17/2025 through the exercise of stock options from the issuer, with the purchase price paid in cash.

What prior CWAN share sales by James Cox are listed in the last 3 months?

The notice lists several recent sales for James Cox under a 10b5-1 sales plan, including 11275 shares sold on 12/15/2025 for $241377.43, 29700 shares on 11/25/2025 for $653400.00, and 11275 shares on 11/17/2025 for $222611.88, among others.

How many CWAN shares are outstanding according to this notice?

The Rule 144 notice states that there are 288154032 shares of the issuer’s common stock outstanding.

On which exchange and through which broker will the CWAN shares be sold?

The planned sale is to occur on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/17/2025 - 04:26 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001441361
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clearwater Analytics Holdings, Inc.
SEC File Number	001-40838
Address of Issuer	777 W. Main Street, Suite 900 Boise IDAHO 83702
Phone	2084331200
Name of Person for Whose Account the Securities are To Be Sold	JAMES COX
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7425	159637.50	288154032	12/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/17/2025	Exercise of Stock Options	Issuer			7425	12/17/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	12/15/2025	11275	241377.43
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	11/25/2025	29700	653400.00
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	11/17/2025	11275	222611.88
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	10/15/2025	11275	202677.50
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	09/30/2025	5919	104631.35

144: Remarks and Signature

Remarks
Date of Notice	12/17/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/11/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Samuel Cox
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)